149 ASPSCR1::TFE3type-1 vs. type-2 fusions in alveolar soft part sarcoma (ASPS) display a differential tumor immune microenvironment (TIME) influencing response to immune checkpoint inhibitors (ICIs)

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Regular and Young Investigator Award Abstracts

Topics

Biology

Cancer Oncology

Computer Science

Medicine

Immunology

Show all topics

DOI

10.1136/jitc-2024-sitc2024.0149

License

CC-BY-NC

Other Formats

PDF